BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 2787356)

  • 1. Induction of class I MHC-restricted, peptide-specific cytolytic T lymphocytes by peptide priming in vivo.
    Ishioka GY; Colon S; Miles C; Grey HM; Chesnut RW
    J Immunol; 1989 Aug; 143(4):1094-100. PubMed ID: 2787356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovalbumin injected with complete Freund's adjuvant stimulates cytolytic responses.
    Ke Y; Li Y; Kapp JA
    Eur J Immunol; 1995 Feb; 25(2):549-53. PubMed ID: 7875219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-priming of cytolytic T cell immunity in vivo using beta 2-microglobulin as an adjuvant.
    Rock KL; Fleischacker C; Gamble S
    J Immunol; 1993 Feb; 150(4):1244-52. PubMed ID: 8381832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic T cell responses to DNA vaccination: dependence on antigen presentation via class II MHC.
    Maecker HT; Umetsu DT; DeKruyff RH; Levy S
    J Immunol; 1998 Dec; 161(12):6532-6. PubMed ID: 9862678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. V beta 5+ T cell receptors skew toward OVA+H-2Kb recognition.
    Dillon SR; Jameson SC; Fink PJ
    J Immunol; 1994 Feb; 152(4):1790-801. PubMed ID: 8120388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Injection of detergent-denatured ovalbumin primes murine class I-restricted cytotoxic T cells in vivo.
    Schirmbeck R; Böhm W; Reimann J
    Eur J Immunol; 1994 Sep; 24(9):2068-72. PubMed ID: 8088327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus class I-restricted peptide induces cytotoxic T lymphocytes in vivo independent of CD4+ T cells.
    Vasilakos JP; Michael JG
    J Immunol; 1993 Mar; 150(6):2346-55. PubMed ID: 8095512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
    Rock KL; Clark K
    J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of antigenic peptides by lymphocyte granule serine proteases (granzymes).
    Carter CR; Sayers TJ; Wiltrout RH; Turcovski-Corrales SM; Taub DD
    Cell Immunol; 1996 Sep; 172(2):235-45. PubMed ID: 8964086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination of class I major histocompatibility complex (MHC)-restricted murine CD8+ cytotoxic T lymphocytes towards soluble antigens: immunostimulating-ovalbumin complexes enter the class I MHC-restricted antigen pathway and allow sensitization against the immunodominant peptide.
    Heeg K; Kuon W; Wagner H
    Eur J Immunol; 1991 Jun; 21(6):1523-7. PubMed ID: 1904363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo and in vitro activation of T cells after administration of Ag-negative heat shock proteins.
    Breloer M; Fleischer B; von Bonin A
    J Immunol; 1999 Mar; 162(6):3141-7. PubMed ID: 10092763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of mutations in the MHC class I peptide binding groove on the cytotoxic T lymphocyte recognition of the Kb-restricted ovalbumin determinant.
    Nikolić-Zugić J; Carbone FR
    Eur J Immunol; 1990 Nov; 20(11):2431-7. PubMed ID: 2253683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitization of MHC class I-restricted T cells to exogenous proteins: evidence for an alternative class I-restricted antigen presentation pathway.
    Martinez-Kinader B; Lipford GB; Wagner H; Heeg K
    Immunology; 1995 Oct; 86(2):287-95. PubMed ID: 7490131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral antigen inhibits priming of CD8+ CTL, CD4+ T cells, and antibody responses while activating CD8+ suppressor T cells.
    Ke Y; Kapp JA
    J Immunol; 1996 Feb; 156(3):916-21. PubMed ID: 8558017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif.
    Lipford GB; Hoffman M; Wagner H; Heeg K
    J Immunol; 1993 Feb; 150(4):1212-22. PubMed ID: 7679422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway.
    Garg N; Nunes MP; Tarleton RL
    J Immunol; 1997 Apr; 158(7):3293-302. PubMed ID: 9120286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saponin adjuvant induction of ovalbumin-specific CD8+ cytotoxic T lymphocyte responses.
    Newman MJ; Wu JY; Gardner BH; Munroe KJ; Leombruno D; Recchia J; Kensil CR; Coughlin RT
    J Immunol; 1992 Apr; 148(8):2357-62. PubMed ID: 1373166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide affinity for MHC influences the phenotype of CD8(+) T cells primed in vivo.
    Ma H; Kapp JA
    Cell Immunol; 2001 Nov; 214(1):89-96. PubMed ID: 11902833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of class I and class II MHC-restricted antigen presentation by cytotoxic T lymphocytes specific for an exogenous antigen.
    Rock KL; Rothstein L; Fleischacker C; Gamble S
    J Immunol; 1992 May; 148(10):3028-33. PubMed ID: 1578128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.